US Patent 9610362 Antisense conjugates for decreasing expression of DMPK
Patent 9610362 was granted and assigned to Valerion Therapeutics on April, 2017 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
March 14, 2013
Date of Patent
April 4, 2017
Patent Applicant
Patent Application Number
14385724
Patent Citations Received
•••
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 9610362 Antisense conjugates for decreasing expression of DMPK
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
